Access, Walgreens broaden relationship to reach underserved populations
CHICAGO — Access Community Health Network and Walgreens have extended their relationship to co-develop an integrated program to provide accessible preventive and primary health care for underserved populations, Access said Monday.
As part of the partnership, Walgreens will work with Access on the following initiatives:
Create a pharmacy and therapeutics committee that will provide prescribing guidelines for all Access health centers to help every patient receive cost-effective, high-quality drug therapies;
Integrate a clinical pharmacy resident with Access’ physicians and nurses at one of Access’ health centers on Chicago’s South Side; and
Open a pharmacy inside the Access Genesis Center for Health and Empowerment health center in Des Plaines, Ill., which predominantly cares for an underserved Hispanic population.
Walgreens currently performs pharmacy services for Access’ more than 50 health centers that participate in the federal 340B program, which offers deep discounts on prescription medications to some of the nation’s most vulnerable patient populations, Access said.
"We are working with Walgreens to co-develop an integrated program that will ease the transition of our patients from in-patient facilities to enjoying healthy lives in the community and preventing hospital readmissions," Access CEO Donna Thompson said. "Through all of these Walgreens initiatives, Access will be better able to meet the needs of patients who often have nowhere else to turn for treatment."
Better glycemic control achieved among diabetics with authoritative parents, study finds
ALEXANDRIA, Va. — Children with Type 1 diabetes may achieve better blood-sugar control if their parents are more authoritative with them, a new study has found.
The study, conducted by researchers at the Israel Diabetes Center of Schneider Children’s Medical Center of Israel and published in the August issue of the journal Diabetes Care, found what they called an association between more authoritative parenting by fathers and better glycemic control in children, while a sense of hopelessness in fathers and mothers was associated with worse glycemic control and adherence. The study enrolled parents and children ages 11 years to 18 years.
More authoritativeness among fathers, but not mothers, was associated with better treatment adherence and glycemic controls, while children with more permissive mothers had worse adherence. Among boys, higher authoritarianism among mothers also was associated with less adherence.
“The findings may help healthcare providers and parents in determining appropriate parental involvement in the daily management of children’s and adolescents’ diabetes needs,” lead researcher Joseph Meyerovitch said. “The association between paternal level of authoritativeness and diabetes control measures highlights the importance of fathers’ involvement in children’s diabetes management. Unfortunately, our clinical experience along with empirical evidence suggests that when compared with mothers, fathers tend to take a too-small role in their child’s diabetes management.”
Welchol oral suspension now can be mixed with fruit juice, diet soft drinks or water
PARSIPPANY, N.J. — The Food and Drug Administration has approved a new means of administration for a drug made by Daiichi Sankyo, the drug maker said Monday.
Daiichi Sankyo announced the FDA approval of Welchol (colesevelam hydrochloride) for oral suspension to be mixed with fruit juice or diet soft drinks. The drug, used to improve blood-sugar control and cholesterol levels in patients with Type 2 diabetes and high cholesterol, received approval in 2009 for mixing with water.
“Since the approval of once-daily Welchol for oral suspension, we’ve seen that patients appreciate the flexible dosing options provided by Welchol, taken as tablets with a meal and liquid or as a drinkable formulation with a meal, to help them reach their [LDL cholesterol] and A1C goals,” Daiichi Sankyo medical director for medical research and head of strategy therapeutic areas Oliseyenum Nwose said. “We are pleased that patients, depending on their preference, can now choose to mix their Welchol for oral suspension with fruit juice, diet soft drinks or water.”